On April 20, 2012, a Pennsylvania mother filed a lawswuit against drug maker Pfizer claiming that her use of Zoloft during pregnancy caused her son to be born with bilateral club feet. Her Zoloft club foot lawsuit, brought in the U.S. District Court for the Eastern District of Pennsylvania in Philadelphia, alleges that Pfizer failed to warn pregnant women of Zoloft birth defects risks.
After being diagnosed with clubfoot at birth, claims the lawsuit, doctors initially tried to treat the birth defects with casting. Unfortunately, attempts at casting failed to correct the condition. In 2007, when he was 9 months old, the baby underwent surgery to treat his clubbed feet. The boy, now 5 years old, “continues to suffer physically and emotional,” according to his lawyers. The attorneys claim that the boy’s pain and suffering was caused by Pfizer’s neglecting to inform doctors and patients of the dangers of using Zoloft in pregnancy.
The lawsuit clams that Pfizer knew of Zoloft’s pregnancy side effects risks, but nonetheless chose to market the drug to pregnant women. Before Zoloft was approved by the FDA in 1991 and released onto the U.S. market, Pfizer conducted animal trials on the drug and found that it caused side effects in animal fetuses. Despite the studies, Pfizer marketed Zoloft to pregnant women and failed to warn of the risks linked to taking the SSRI antidepressant during pregnancy, the suit alleges.
Following its approval in 1991, numerous Zoloft lawsuits have been filed across the U.S. to recover compensation for personal injury and wrongful death damages caused by Zoloft birth defects. A growing body of medical research is shedding light on the side effects of Zoloft and other SSRI antidepressants, including Paxil, Prozac, Celexa, Lexapro, and Luvox.
In 2005, the FDA required that a black box warning be added to Zoloft’s label warning that it could increase the risk of suicide in children and adolescents. In 2006, a study was published in the New England Journal of Medicine that linked use of Zoloft while pregnant to persistent pulmonary hypertension of the newborn (PPHN), a congenital heart/lung defect. In 2007, the FDA required a revision to the the Zoloft black box warning to include increased pregnancy risks of PPHN and Zoloft heart defects.
The Pennsylvania Zoloft club foot lawsuit seeks financial compensation for the emotional and financial costs and damages associated with treatment of the bilateral clubbed feet and damages to protect other women and children from suffering similar injuries and damages.
Zoloft Club Foot Lawsuit
Our lawyers currently are helping families affected by Zoloft club foot birth defects. If your child was born with a birth defect after you used Zoloft while pregnant, please contact us so one of our experienced attorneys can help you. We are here to listen, provide information, and/or give you options about taking legal action and filing a Zoloft club foot lawsuit.